...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of the advanced practitioner in oncology >Exploring the Use of Medical Marijuana for Supportive Care of Oncology Patients
【24h】

Exploring the Use of Medical Marijuana for Supportive Care of Oncology Patients

机译：探索医疗大麻的使用进行肿瘤患者的支持性护理

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Medical marijuana, also known as cannabis, is being sought by patients and survivors to alleviate common symptoms of cancer and its treatments that affect their quality of life. The National Academy of Sciences (2017) reports conclusive or substantial evidence that cannabis is successful in treating chronic cancer pain and chemotherapy-induced nausea and vomiting, moderate evidence that cannabinoids are beneficial for sleep disorders that accompany chronic illnesses, and limited evidence supporting use for appetite stimulation and anxiety. However, due to the fact that cannabis is classified as a Schedule I controlled substance, there is an absence of rigorous, scientific evidence to guide health-care professionals. In addition, the Schedule I designation makes it illegal for health-care professionals in the United States to prescribe, administer, or directly distribute these drugs. Legislation has outpaced research in this area. Therefore, the National Council of State Boards of Nursing (NCSBN) appointed a medical marijuana guideline committee to create guidelines for the nursing care of patients using medical marijuana, marijuana education in nursing programs, and guidelines for advanced practice registered nurses (APRNs) certifying a patient for the use of medical marijuana (The NCSBN Medical Marijuana Guidelines Committee, 2018). Six states/districts authorize APRNs to recommend the use of medical marijuana to patients with qualifying conditions (Kaplan, 2015). As of March 2021, 35 states plus the District of Columbia have authorized the use of medical marijuana (DISA Global Solutions, 2021). Therefore, APRNs will be caring for these patients and need to know the medical, pharmacological, and legal issues surrounding medical cannabis use.
机译：患者和幸存者正在寻找医用大麻，以缓解癌症的常见症状以及影响他们生活质量的治疗方法。美国国家科学院（2017年）报告了确凿或实质性证据，证明大麻能成功治疗慢性癌症疼痛和化疗引起的恶心呕吐，有中度证据表明大麻素有益于慢性疾病伴发的睡眠障碍，支持用于刺激食欲和焦虑的证据有限。然而，由于大麻被列为附表一管制物质，因此缺乏严格的科学证据来指导卫生保健专业人员。此外，附表I规定，美国的医疗保健专业人员开处方、管理或直接分销这些药物是非法的。这方面的立法速度超过了研究。因此，美国国家护理委员会（NCSBN）任命了一个医用大麻指导委员会，为使用医用大麻的患者的护理、护理项目中的大麻教育、，以及《高级执业注册护士（APRN）使用医用大麻认证指南》（NCSBN医用大麻指南委员会，2018年）。六个州/地区授权澳大利亚审慎监管局向符合条件的患者推荐使用医用大麻（Kaplan，2015）。截至2021年3月，35个州和哥伦比亚特区已经批准使用医用大麻（DISA全球解决方案，2021）。因此，APRNs将照顾这些患者，并需要了解有关医用大麻使用的医疗、药理学和法律问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号